A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.
M1 Kliniken AG (von First Berlin Equity Research GmbH) – Biotech Investments
Original-Research: M1 Kliniken AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu M1 Kliniken AG Unternehmen: M1 Kliniken